Agentic identity management for healthcare AI agents and governance

At a glance

What this is: Imprivata’s new agentic identity management capability treats healthcare AI agents as managed identities and focuses on short-lived access, monitoring, and revocation across clinical and legacy systems.

Why it matters: It matters because healthcare AI adds a new identity subject type into already tightly governed environments, forcing IAM, PAM, and IGA teams to extend controls without breaking patient-safety workflows or compliance obligations.

👉 Read Imprivata's announcement on agentic identity management for healthcare AI agents

Context

Healthcare AI agents are software entities that can take actions across clinical and operational systems, but they still depend on identity controls to be trusted, limited, and audited. The core problem is not just automation, it is whether these agents can be governed with the same discipline applied to human and machine identities in regulated environments.

In healthcare, the identity gap is sharper because access decisions affect patient safety, availability, and protected health information. Imprivata is framing the issue around a practical governance question: how to let agents operate across modern and legacy systems while keeping clinicians in control and preserving Zero Trust, least privilege, and auditability.

Key questions

Q: How should security teams govern AI agents in healthcare environments?

A: Treat AI agents as managed identities with explicit ownership, defined scopes, continuous monitoring, and real-time revocation. In healthcare, the control set must extend across clinical systems, legacy applications, and regulated workflows so the agent never operates outside an auditable boundary. Clinicians should remain the accountable decision-makers for patient-impacting actions.

Q: Why do AI agents create new identity risk in clinical workflows?

A: AI agents can act across systems, time, and tasks in ways that do not fit static human access models. That creates risk when permissions are broad, credentials persist too long, or legacy integrations lack fine-grained controls. In regulated care settings, the challenge is not only access, but traceability, accountability, and safe override.

Q: What breaks when AI agents are governed like ordinary service accounts?

A: You lose the ability to express task-specific intent, operational context, and human accountability. Ordinary service-account patterns often assume a fixed workload and a stable permission set, while agentic behaviour can shift across workflows and systems. That mismatch creates excess privilege, poor audit clarity, and weak control over regulated actions.

Q: What is the difference between controlling AI agents and controlling human users?

A: Human controls focus on authentication, session assurance, and user behaviour, while AI agent controls must also manage runtime scope, delegated actions, and system-to-system access. In healthcare, the difference matters because an agent can act at machine speed across multiple systems, so governance must cover lifecycle, authorization, monitoring, and revocation together.

How it works in practice

Managed identities for AI agents in clinical systems

The vendor’s model treats an AI agent as a managed identity rather than as an application feature or a generic automation layer. That means the agent gets an identity object, defined roles, and access permissions that can be governed in the same control plane as other enterprise identities. In practice, this is about binding runtime behaviour to explicit identity records so activity can be monitored, limited, and revoked. In healthcare, that design matters because clinical workflows often span legacy applications, EHRs, and shared operational systems that were never built for autonomous access subjects.

Practical implication: identity teams should decide whether AI agents belong in the same governance inventory as service accounts, applications, and privileged users.

Short-lived tokens, least privilege, and revocation

Short-lived tokens reduce credential persistence by narrowing the window in which an agent can use access, while least privilege constrains what that access can reach. The important architectural detail is that these controls work together: a short-lived credential without tight scope still overexposes systems, and least privilege without revocation still leaves stale access in circulation. The vendor’s framing also includes real-time monitoring and access limitation, which indicates a governance pattern built for high-churn clinical activity rather than static entitlement sets. That is materially different from traditional shared-account administration.

Practical implication: teams should map every agent permission to a bounded task, then verify that revocation is operationally available when task scope changes.

Why legacy healthcare integration changes the control model

Healthcare AI governance is harder because agent access has to reach both modern and legacy infrastructure. Legacy systems often rely on brittle authentication patterns, coarse entitlements, and limited telemetry, which makes agent governance more difficult than in greenfield environments. When an agent needs to touch EHR workflows, scheduling, pharmacy, or lab systems, the control question becomes whether the access path can be mediated without creating standing privilege or invisible lateral movement. Zero Trust and privileged access controls are relevant here because they force each interaction to be explicit, attributable, and reviewable.

Practical implication: security architects should test whether legacy integration points can actually support per-agent governance before expanding AI usage into regulated workflows.

NHI Mgmt Group analysis

Healthcare agentic identity is now an access governance problem, not just an AI adoption problem. The vendor’s move shows that the security question has shifted from whether AI can help clinicians to whether an AI system can be made governable inside a regulated identity stack. That matters because healthcare systems already run on tightly controlled access paths, and agentic behaviour adds a new subject that can act across systems without fitting human IAM assumptions. Practitioners should treat this as an identity architecture change, not a chatbot deployment.

Least privilege for AI agents in healthcare must be task-bounded, not role-bounded. Healthcare workflows are too dynamic for broad standing entitlements that mirror human job roles. An agent that supports triage, documentation, or scheduling does not need the same access pattern across all those tasks, and role reuse can quickly turn into excess privilege. The practical conclusion is that agent governance has to align permissions to workflow fragments and clinical context, not just titles or departments.

Clinician-in-the-loop controls remain the accountability anchor, even when agents act autonomously within workflow boundaries. The vendor is explicit that clinicians must remain in control, which reflects a deeper governance truth in healthcare: automation cannot replace accountable human oversight for regulated decisions. That applies equally to NHI and autonomous systems when the output can affect patient safety or PHI handling. Security and compliance teams should keep escalation, review, and override paths visible in every agentic workflow.

Managed identity for AI agents should become a distinct control category in healthcare IAM. AI agents are neither ordinary users nor ordinary service accounts because they can operate across multiple systems with variable intent and runtime behaviour. That means healthcare identity programmes need a specific classification and lifecycle for agents, including onboarding, authorization, monitoring, and revocation. The practitioner takeaway is to stop forcing agent identities into categories built for humans or static workloads.

Zero Trust in healthcare is only credible when it covers agent access to legacy systems. A modern access model is incomplete if it protects new apps but leaves old clinical systems exposed through broad connectors or shared credentials. The same access philosophy has to reach every system that can influence care, billing, or PHI. Practitioners should assume legacy integration is where agent governance will either succeed operationally or fail in practice.

From our research:

• 92% agree governing AI agents is critical to enterprise security, yet only 44% have implemented any policies to do so, according to AI Agents: The New Attack Surface report.
• 52% of companies can track and audit the data their AI agents access, leaving 48% with a complete blind spot for compliance and breach investigation.
• For the adjacent control model, see OWASP Agentic AI Top 10 for the agent-risk patterns that need identity governance support.

What this signals

Agent governance will increasingly sit between IAM and clinical operations. Healthcare teams that already manage human identities, service accounts, and privileged access will need a separate operating model for AI agents because the workflow impact is immediate and regulated. The practical shift is toward task-scoped authorisation, tighter telemetry, and explicit accountability for every agent action.

Managed identity for AI agents should be treated as a control plane, not a point feature. If agent governance is bolted onto existing access tooling without lifecycle and revocation discipline, the result will be visible access sprawl rather than safer automation. The programme signal is clear: policy, audit, and approval paths need to be designed for machine-paced activity, not human review cadence.

Agentic care workflows will expose the same lifecycle weakness that has long affected NHI programmes. When access is provisioned quickly for a new use case but decommissioning is vague, governance debt accumulates fast. Teams should use the Ultimate Guide to NHIs and the NHI lifecycle section to pressure-test how onboarding, revocation, and exception handling would work for agents in live clinical environments.

For practitioners

• Define a distinct identity class for AI agents Create a separate governance category for AI agents so provisioning, approval, monitoring, and revocation are handled differently from human users and workload accounts. Tie each agent to a named business owner and an accountable clinical workflow.
• Bind agent access to task-specific scopes Assign the smallest possible permissions for each clinical workflow and avoid broad role bundles that let one agent move across documentation, triage, scheduling, and pharmacy without reauthorization.
• Require short-lived credentials with live revocation Use short-lived tokens for agent sessions and verify that access can be revoked in real time when a workflow ends, a model changes behaviour, or the agent touches an unapproved system.
• Test legacy system access paths before scaling use cases Validate how agents authenticate to EHRs and older clinical systems, including audit logging, entitlement granularity, and break-glass controls, before extending the programme beyond a pilot.
• Keep clinicians accountable for regulated actions Document where human approval, review, or override remains mandatory for patient-impacting tasks so that agent automation never creates an ambiguous accountability chain.

Key takeaways

• Healthcare AI agents create a new identity governance layer because they can act across clinical systems, legacy infrastructure, and regulated workflows.
• The strongest control pattern in the source is short-lived, task-bounded access with live monitoring and revocation, not broad role reuse.
• The practical limit is accountability: clinicians must remain in the loop for patient-impacting actions, or agent automation becomes a governance liability.

Key terms

• Agentic Identity: An agentic identity is the identity record used to govern an AI agent that can take actions across systems. It should carry ownership, scope, auditability, and revocation controls so the agent is managed like a distinct operational subject, not hidden inside an application account.
• Task-bounded Access: Task-bounded access is permissioning tied to a specific workflow fragment rather than a broad role or department. For AI agents, this means the access window, systems touched, and actions allowed all map to the immediate task, reducing excess privilege and limiting regulated exposure.
• Clinician-in-the-loop: Clinician-in-the-loop means a human healthcare professional remains accountable for decisions that affect care, safety, or regulated data handling. In agentic environments, it preserves oversight by ensuring the AI can assist, but not silently own, patient-impacting actions.

Deepen your knowledge

Healthcare agentic identity governance is a core topic in the NHI Foundation Level course, the industry's only accredited NHI security programme. If you are extending identity controls into clinical AI workflows, it is worth exploring.

This post draws on content published by Imprivata: Agentic Identity Management for healthcare AI agents. Read the original.